Option Care(OPCH) - 2025 Q3 - Quarterly Results

Financial Performance - Option Care Health reported net revenue of $1,435.0 million for Q3 2025, representing a year-over-year increase of 12.2%[3] - Gross profit for the third quarter was $272.9 million, up 6.3% compared to the previous year[3] - Net income for Q3 2025 was $51.8 million, a decrease of 3.8% from the previous year[3] - Adjusted EBITDA for Q3 2025 increased to $119,498,000, up 3.3% from $115,583,000 in Q3 2024[15] - Adjusted net income for the nine months ended September 30, 2025, was $207,810,000, representing a 5.8% increase from $197,329,000 in the same period of 2024[15] - Diluted earnings per share for Q3 2025 was $0.32, compared to $0.31 in Q3 2024, reflecting a 3.2% increase[15] - Adjusted diluted earnings per share rose to $0.45 in Q3 2025, up 9.8% from $0.41 in Q3 2024[15] Cash Flow and Assets - Year-to-date cash provided by operating activities reached $222.6 million[3] - Cash and cash equivalents at the end of Q3 2025 were $309.8 million, down from $412.6 million at the beginning of the period[14] - Total assets as of September 30, 2025, were $3.48 billion, compared to $3.42 billion at the end of 2024[12] Future Projections - The company expects full-year 2025 net revenue to be between $5.60 billion and $5.65 billion, with adjusted diluted earnings per share projected at $1.68 to $1.72[4] - Adjusted EBITDA for the full year is expected to be between $468 million and $473 million[4] Stock and Debt Management - The company repurchased $62.5 million of stock during the quarter[3] - The company expanded its term loan by $49.6 million and reduced its interest rate[3] Expense and Tax Adjustments - Interest expense, net, increased to $14,146,000 in Q3 2025 from $12,345,000 in Q3 2024, a rise of 14.6%[15] - Depreciation and amortization expense for Q3 2025 was $17,048,000, up from $15,227,000 in Q3 2024, reflecting an increase of 11.9%[15] - Tax adjustments for the nine months ended September 30, 2025, were $(20,634,000), compared to $(15,294,000) in the same period of 2024, indicating a higher tax impact from non-GAAP adjustments[15] Shareholder Information - Weighted average common shares outstanding, diluted, decreased to 163,086,000 in Q3 2025 from 171,941,000 in Q3 2024[15] - Total pre-tax adjustments for Q3 2025 amounted to $28,606,000, compared to $23,053,000 in Q3 2024, indicating a 24.1% increase[15]